News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in MedicineShorts
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Emerging Pharma Leaders Awards|
Latest Executive Roundtables|
Asembia 2025 |
Sales Effectiveness
Advertisement

Alice Valder Curan

Advertisement

Alice Valdur Curan is partner at Hogan Lowells.

Articles by Alice Valder Curan

Alice Valdur Curran

The Ongoing Impact of MFN Pricing

ByMike Hollan,Alice Valder Curan
March 5th 2026

Alice Valder Curran discusses how the industry continues to strategize around this complicated order.

Advertisement

Latest Updated Articles

  • Alice Valdur Curran
    The Ongoing Impact of MFN Pricing

    March 5th 2026



Advertisement
Advertisement

Trending on PharmExec

1

Roche and C4 Therapeutics Expands Partnership with $1 Billion Collaboration Agreement

2

Aradhana Sarin: The CFO as a Catalyst

3

Lipid Lowering with PCSK9 Inhibition: Long-Term Efficacy, Long-Standing Barriers

4

Medical Supply Chains at Risk Over Escalating Conflicts in Iran: Report

5

Shionogi Inc. Awarded $482 Million Contract with U.S. Government to Enhance National Preparedness for Drug-Resistant Bacterial Threats

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us